Status:
COMPLETED
Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
10+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension, 0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating inflammation i...
Eligibility Criteria
Inclusion
- planned cataract extraction with posterior chamber intraocular lens implantation
Exclusion
- Under 10
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
267 Patients enrolled
Trial Details
Trial ID
NCT00333255
Start Date
September 1 2005
Last Update
July 8 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lehmann Eye Center
Nacogdoches, Texas, United States, 76134